From the operating room to the courtroom: A comprehensive characterization of litigation related to facial plastic surgery procedures

被引:81
作者
Svider, Peter F. [1 ,4 ]
Keeley, Brieze R. [5 ]
Zumba, Osvaldo [6 ]
Mauro, Andrew C. [7 ]
Setzen, Michael [8 ,9 ]
Eloy, Jean Anderson [1 ,2 ,3 ]
机构
[1] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Otolaryngol Head & Neck Surg, Newark, NJ 07103 USA
[2] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol Surg, Newark, NJ 07103 USA
[3] Univ Med & Dent New Jersey, New Jersey Med Sch, Ctr Skull Base & Pituitary Surg, Newark, NJ 07103 USA
[4] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ USA
[5] Mt Sinai Sch Med, New York, NY USA
[6] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Surg, New Brunswick, NJ 08903 USA
[7] Univ Michigan, Sch Law, Ann Arbor, MI 48109 USA
[8] N Shore Univ Hosp, Rhinol Sect, Manhasset, NY USA
[9] NYU, Sch Med, Dept Otolaryngol, New York, NY USA
关键词
Medicolegal; facial plastic surgery malpractice; litigation; liability; MEDICAL MALPRACTICE; CANCER;
D O I
10.1002/lary.23905
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives/Hypothesis Malpractice litigation has increased in recent decades, contributing to higher health-care costs. Characterization of complications leading to litigation is of special interest to practitioners of facial plastic surgery procedures because of the higher proportion of elective cases relative to other subspecialties. In this analysis, we comprehensively examine malpractice litigation in facial plastic surgery procedures and characterize factors important in determining legal responsibility, as this information may be of great interest and use to practitioners in several specialties. Study Design Retrospective analysis. Methods The Westlaw legal database was examined for court records pertaining to facial plastic surgery procedures. The term medical malpractice was searched in combination with numerous procedures obtained from the American Academy of Facial Plastic and Reconstructive Surgery website. Results Of the 88 cases included, 62.5% were decided in the physician's favor, 9.1% were resolved with an out-of-court settlement, and 28.4% ended in a jury awarding damages for malpractice. The mean settlement was $577,437 and mean jury award was $352,341. The most litigated procedures were blepharoplasties and rhinoplasties. Alleged lack of informed consent was noted in 38.6% of cases; other common complaints were excessive scarring/disfigurement, functional considerations, and postoperative pain. Conclusions This analysis characterized factors in determining legal responsibility in facial plastic surgery cases. Several factors were identified as potential targets for minimizing liability. Informed consent was the most reported entity in these malpractice suits. This finding emphasizes the importance of open communication between physicians and their patients regarding expectations as well as documentation of specific risks, benefits, and alternatives.
引用
收藏
页码:1849 / 1853
页数:5
相关论文
共 18 条
[11]   Medical malpractice and cancer of the larynx [J].
Lydiatt, DD .
LARYNGOSCOPE, 2002, 112 (03) :445-448
[12]  
Mavroforou Anna, 2004, Med Law, V23, P479
[13]   A review of litigation in plastic surgery in England. Lessons learned [J].
Mehta, S. ;
Farhadi, J. ;
Atrey, A. .
JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2010, 63 (10) :1747-1748
[14]  
Quality Interagency Coordination Task Force, 2012, DOING WHAT COUNTS PA
[15]   Thyroidectomy-Related Malpractice Claims [J].
Singer, Michael C. ;
Iverson, Kenneth C. ;
Terris, David J. .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2012, 146 (03) :358-361
[16]   Incidence and types of adverse events and negligent care in Utah and Colorado [J].
Thomas, EJ ;
Studdert, DM ;
Burstin, HR ;
Orav, EJ ;
Zeena, T ;
Williams, EJ ;
Howard, KM ;
Weiler, PC ;
Brennan, TA .
MEDICAL CARE, 2000, 38 (03) :261-271
[17]  
U. S. Department of Health and Human Services Food and Drug Administration, 2011, GUID IND OV CLIN INV
[18]  
US Food and Drug Administration, 2012, DOES FDA MON SAF DRU